{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:08:43Z","timestamp":1791950923237,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T00:00:00Z","timestamp":1117065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T00:00:00Z","timestamp":1117065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1038\/sj.leu.2403814","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T16:33:30Z","timestamp":1117125210000},"page":"1355-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity"],"prefix":"10.1038","volume":"19","author":[{"given":"U","family":"Creutzig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Diekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dworzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,26]]},"reference":[{"key":"BF2403814_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1055\/s-2007-1025529","volume":"202","author":"U Creutzig","year":"1990","unstructured":"Creutzig U, Ritter J, Vormoor J, Eschenbach C, Dickerhoff R, Burdach S et al. Transiente Myeloproliferation und akute myeloische Leuk\u00e4mie bei S\u00e4uglingen mit Morbus Down. Klin P\u00e4diatr 1990; 202: 253\u2013257.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403814_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0022-3476(84)80119-5","volume":"105","author":"LL Robison","year":"1984","unstructured":"Robison LL, Nesbit MEJ, Sather HN, Level C, Shahidi N, Kennedy A et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group. J Pediatr 1984; 105: 235\u2013242.","journal-title":"J Pediatr"},{"key":"BF2403814_CR3","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1182\/blood.V76.11.2348.2348","volume":"76","author":"S Kojima","year":"1990","unstructured":"Kojima S, Matsuyama T, Sato T, Horibe K, Konishi S, Tsuchida M, Okamura J et al. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 1990; 76: 2348\u20132353.","journal-title":"Blood"},{"key":"BF2403814_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0145-2126(94)90111-2","volume":"18","author":"A Zipursky","year":"1994","unstructured":"Zipursky A, Thorner P, De Harven E, Christensen H, Doyle J . Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leukemia Res 1994; 18: 163\u2013171.","journal-title":"Leukemia Res"},{"key":"BF2403814_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/08880018709141272","volume":"4","author":"A Zipursky","year":"1987","unstructured":"Zipursky A, Peeters M, Poon A . Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr Hematol Oncol 1987; 4: 211\u2013230.","journal-title":"Pediatr Hematol Oncol"},{"key":"BF2403814_CR6","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1182\/blood.V80.9.2210.2210","volume":"80","author":"Y Ravindranath","year":"1992","unstructured":"Ravindranath Y, Abella E, Krischer JP, Wiley J, Inoue S, Harris M et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood 1992; 80: 2210\u20132214.","journal-title":"Blood"},{"key":"BF2403814_CR7","first-page":"1677","volume":"10","author":"U Creutzig","year":"1996","unstructured":"Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I et al. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia 1996; 10: 1677\u20131686.","journal-title":"Leukemia"},{"key":"BF2403814_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189\u2013199.","journal-title":"Br J Haematol"},{"key":"BF2403814_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.7326\/0003-4819-103-3-460","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French\u2013American\u2013British Cooperative Group. Ann Intern Med 1985; 103: 460\u2013462.","journal-title":"Ann Intern Med"},{"key":"BF2403814_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.7326\/0003-4819-103-4-626","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 626\u2013629.","journal-title":"Ann Intern Med"},{"key":"BF2403814_CR11","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V86.8.3097.3097","volume":"86","author":"U Creutzig","year":"1995","unstructured":"Creutzig U, Sperling CH, Harbott J, Ritter J, Zimmermann M, L\u00f6ffler H et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of Study AML-BFM-87. Blood 1995; 86: 3097\u20133108.","journal-title":"Blood"},{"key":"BF2403814_CR12","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1200\/JCO.2001.19.10.2705","volume":"19","author":"U Creutzig","year":"2001","unstructured":"Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F et al. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia \u2013 Berlin\u2013Frankfurt\u2013Munster 93. J Clin Oncol 2001; 19: 2705\u20132713.","journal-title":"J Clin Oncol"},{"key":"BF2403814_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/adc.81.1.32","volume":"81","author":"JL Craze","year":"1999","unstructured":"Craze JL, Harrison G, Wheatly K, Hann IM, Chessells JM . Improved outcome of acute myeloid leukaemia in Down's syndrome. Arch Dis Child 1999; 81: 32\u201337.","journal-title":"Arch Dis Child"},{"key":"BF2403814_CR14","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood.V81.11.3164.3164","volume":"81","author":"S Kojima","year":"1993","unstructured":"Kojima S, Kato K, Matsuyama T, Yoshikawa T, Horibe K . Favorable treatment outcome in children with acute myeloid leukemia and Down syndrome. Blood 1993; 81: 3164.","journal-title":"Blood"},{"key":"BF2403814_CR15","first-page":"608","volume":"91","author":"BJ Lange","year":"1998","unstructured":"Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB et al. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 1998; 91: 608\u2013615.","journal-title":"Blood"},{"key":"BF2403814_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1055\/s-2008-1046530","volume":"207","author":"U Creutzig","year":"1995","unstructured":"Creutzig U, Ritter J, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M et al. Akute myeloische Leuk\u00e4mie bei Kindern mit Down-Syndrom. Klin P\u00e4diatr 1995; 207: 136\u2013144.","journal-title":"Klin P\u00e4diatr"},{"key":"BF2403814_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0145-2126(98)00016-2","volume":"22","author":"P Zubizarreta","year":"1998","unstructured":"Zubizarreta P, Felice MS, Alfaro E, Fraquelli L, Casak S, Quinteros R et al. Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy. Leukemia Res 1998; 22: 465\u2013472.","journal-title":"Leukemia Res"},{"key":"BF2403814_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1365-2141.1996.d01-1761.x","volume":"94","author":"SO Lie","year":"1996","unstructured":"Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G . A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol 1996; 94: 82\u201388.","journal-title":"Br J Haematol"},{"key":"BF2403814_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.20242","volume":"44","author":"Y Ravindranath","year":"2005","unstructured":"Ravindranath Y . Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment. Pediatr Blood Cancer 2005; 44: 1\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"BF2403814_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.leu.2401753","volume":"14","author":"BM Frost","year":"2000","unstructured":"Frost BM, Gustafsson G, Larsson R, Nygren P, Lonnerholm G . Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Leukemia 2000; 14: 943\u2013944.","journal-title":"Leukemia"},{"key":"BF2403814_CR21","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood.V87.8.3395.bloodjournal8783395","volume":"87","author":"JW Taub","year":"1996","unstructured":"Taub JW, Matherly LH, Stout ML, Buck SA, Gurney JG, Ravindranath Y . Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. Blood 1996; 87: 3395\u20133403.","journal-title":"Blood"},{"key":"BF2403814_CR22","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/sj.leu.2400747","volume":"11","author":"JW Taub","year":"1997","unstructured":"Taub JW, Stout ML, Buck SA, Huang X, Vega RA, Becton DL et al. Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin. Leukemia 1997; 11: 1594\u20131595.","journal-title":"Leukemia"},{"key":"BF2403814_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1182\/blood.V99.1.245","volume":"99","author":"CM Zwaan","year":"2002","unstructured":"Zwaan CM, Kaspers GJ, Pieters R, Hahlen K, Janka-Schaub GE, Van Zantwijk CH et al. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood 2002; 99: 245\u2013251.","journal-title":"Blood"},{"key":"BF2403814_CR24","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1182\/blood.V97.12.3727","volume":"97","author":"UH Athale","year":"2001","unstructured":"Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood 2001; 97: 3727\u20133732.","journal-title":"Blood"},{"key":"BF2403814_CR25","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1200\/JCO.2003.08.060","volume":"21","author":"AS Gamis","year":"2003","unstructured":"Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR et al. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. J Clin Oncol 2003; 21: 3415\u20133422.","journal-title":"J Clin Oncol"},{"key":"BF2403814_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2141.2005.05398.x","volume":"128","author":"B Zeller","year":"2005","unstructured":"Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J et al. Acute leukaemia in children with Down syndrome: a population-based Nordic Study. Br J Haematol 2005; 128: 797\u2013804.","journal-title":"Br J Haematol"},{"key":"BF2403814_CR27","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1200\/JCO.2003.05.086","volume":"21","author":"Y Ravindranath","year":"2003","unstructured":"Ravindranath Y . Down syndrome and acute myeloid leukemia: the paradox of increased risk for leukemia and heightened sensitivity to chemotherapy. J Clin Oncol 2003; 21: 3385\u20133387.","journal-title":"J Clin Oncol"},{"key":"BF2403814_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJM199103213241205","volume":"324","author":"SE Lipshultz","year":"1991","unstructured":"Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan S, Sanders SP . Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 324: 808\u2013815.","journal-title":"N Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403814","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:28:08Z","timestamp":1648776488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,26]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["BF2403814"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403814","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,26]]},"assertion":[{"value":"18 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}